Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie hit with $140M verdict in second bellwether AndroGel case
AbbVie hit with $140M verdict in second bellwether AndroGel case
AbbVie hit with $140M verdict in second bellwether AndroGel case
Submitted by
admin
on October 6, 2017 - 11:39am
Source:
Fierce Pharma
News Tags:
AbbVie
Androgel
heart attacks
testosterone
Headline:
AbbVie hit with $140M verdict in second bellwether AndroGel case
Do Not Allow Advertisers to Use My Personal information
